U.S. markets closed
  • S&P Futures

    4,007.00
    +3.75 (+0.09%)
     
  • Dow Futures

    34,026.00
    +40.00 (+0.12%)
     
  • Nasdaq Futures

    11,810.00
    +4.25 (+0.04%)
     
  • Russell 2000 Futures

    1,843.60
    +1.70 (+0.09%)
     
  • Crude Oil

    77.36
    +0.43 (+0.56%)
     
  • Gold

    1,784.50
    +3.20 (+0.18%)
     
  • Silver

    22.52
    +0.10 (+0.46%)
     
  • EUR/USD

    1.0496
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    3.5990
    +0.0930 (+2.65%)
     
  • Vix

    20.75
    +1.69 (+8.87%)
     
  • GBP/USD

    1.2205
    +0.0011 (+0.09%)
     
  • USD/JPY

    136.8170
    +0.1320 (+0.10%)
     
  • BTC-USD

    17,003.61
    -212.79 (-1.24%)
     
  • CMC Crypto 200

    401.55
    -9.66 (-2.35%)
     
  • FTSE 100

    7,567.54
    +11.31 (+0.15%)
     
  • Nikkei 225

    27,910.42
    +90.02 (+0.32%)
     

Amylyx Shows FDA Can Be Flexible on Drugs for Diseases With Few Treatments

Amylyx Shows FDA Can Be Flexible on Drugs for Diseases With Few Treatments

Relvyrio, Amylyx's drug to treat ALS, a neurological disorder without a cure, was approved even though the treatment is very expensive.